# Cryocompression With or Without Cilostazol for the Prevention of Paclitaxel-induced Neuropathy in Patients With Gynecological Cancers

> **NCT06492070** · PHASE2 · RECRUITING · sponsor: **Emory University** · enrollment: 70 (estimated)

## Conditions studied

- Cervical Carcinoma
- Fallopian Tube Carcinoma
- Malignant Solid Neoplasm
- Malignant Uterine Neoplasm
- Ovarian Carcinoma
- Primary Peritoneal Carcinoma
- Vulvar Carcinoma

## Interventions

- **OTHER:** Best Practice
- **DRUG:** Cilostazol
- **DEVICE:** Cryocompression Therapy
- **DRUG:** Paclitaxel
- **OTHER:** Quality-of-Life Assessment

## Key facts

- **NCT ID:** NCT06492070
- **Lead sponsor:** Emory University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-08-01
- **Primary completion:** 2026-12-31
- **Final completion:** 2027-12-31
- **Target enrollment:** 70 (ESTIMATED)
- **Last updated:** 2025-08-27

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06492070

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06492070, "Cryocompression With or Without Cilostazol for the Prevention of Paclitaxel-induced Neuropathy in Patients With Gynecological Cancers". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT06492070. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*